We use cookies to enhance your site experience.
This website stores data such as cookies to enable essential site functionality, as well as marketing, personalization and analytics. By continuing to use our website, you consent to cookies being used. Review our Privacy Policy for more information.

Skip to Main Content
American Society for Radiation Oncology
Register now
September 27 - October 1, 2025
Moscone Center, San Francisco, CA
  • Daily Schedule
  • Posters & Abstracts
    • Posters
    • Abstracts
  • Exhibitors
    • Featured Exhibitors
    • All Exhibitors
    • Floor Plan
  • Exhibitor Events
  • Product Showcase
  • Evaluate/Claim Credit
  • Meeting Info
    • On-site Services
    • Registration Hours
    • Food Services
    • Affiliated Meetings
  • Convention Center Maps
  • Event Support
  • Event Code of Conduct
Register now
  1. Home
  2. Hongyuan Jia
Sichuan Cancer Hospital and Institute
Chengdu, Sichuan

Disclosures:

Presentations

Sep 29

2770 - A Randomized, Controlled, Single-Blind, Multicenter Phase II/III Clinical Trial of PD-1 Inhibitor Combined with Chemoradiotherapy for the Treatment of T1-2N2-3/T3-4N0-3M0 Stage Nasopharyngeal Carcinom

Hall F
10:45am - 12:00pm PT
September 27 - October 1, 2025
Moscone Center, San Francisco, CA
Useful links
  • Daily Schedule
  • Posters
  • Abstracts
  • Exhibitors
  • Annual Meeting Site
  • ASTRO.org
Let's Connect
  • X
  • Instagram
  • LinkedIn
  • Facebook
  • ROHub
  • ASTROBlog
© 2025 American Society for Radiation Oncology